Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5

Proteomics

Volumn 8, Issue 2, 2008, Pages 289-300

  Kozielski, Frank ^a   Skoufias, Dimitrios A ^b   Indorato, Rose Laure ^b   Saoudi, Yasmina ^c   Jungblut, Peter R ^d   Hustoff, Hanne K ^e   Strozynski, Margarita ^e   Thiede, Bernd ^e  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Apoptosis; Kinesin; Mitotic arrest; STLC; Taxol

Indexed keywords

ALPHA TUBULIN; AURORA A KINASE; BUB1 RELATED PROTEIN; CASPASE 3; CASPASE 8; CASPASE 9; CYSTEINE DERIVATIVE; GREEN FLUORESCENT PROTEIN; HISTONE H3; KINESIN; PACLITAXEL DERIVATIVE; PROTEIN SAM68; STATHMIN; TRITYL DERIVATIVE; TUMOR PROTEIN;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME DEGRADATION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; RNA BINDING; SEQUENCE HOMOLOGY;

APOPTOSIS; CYSTEINE; HELA CELLS; HUMANS; KINESIN; MITOSIS; PACLITAXEL; PROTEOME; SIGNAL TRANSDUCTION;

EID: 38949179546     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700534     Document Type: Article

References (65)

1. Dutcher, S. K., The tubulin fraternity: Alpha to eta. Curr. Opin. Cell Biol. 2001, 13, 49-54.
2. Jordan, M. A., Wilson, L., Microtubules and actin filaments: Dynamic targets for cancer chemotherapy. Curr. Opin. Cell Biol. 1998, 10, 123-130.
3. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., McPhail, A. T., Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 1971, 93, 2325-2327.
4. Johnson, I. S., Wreight, H. F., Svoboda, G. H., Experimental basis for clinical evaluation of anti tumor principles derived from Vinca rosea Linn. J. Lab. Clin. Med. 1959, 54, 830.
5. Wilson, L., Jordan, M. A., Microtubule dynamics: Taking aim at a moving target. Chem. Biol. 1995, 2, 569-573.
6. Jordan, M. A., Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr. Med. Chem. Anticancer Agents 2002, 2, 1-17.
7. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B. et al., Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996, 56, 816-825.
8. Chen, J. G., Yang, C. P., Cammer, M., Horwitz, S. B., Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res. 2003, 63, 7891-7899.
9. Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., Gottesman, M. M., P-glycoprotein: From genomics to mechanism. Oncogene 2003, 22, 7468-7485.
10. Kavallaris, M., Tait, A. S., Walsh, B. J., He, L. et al., Multiple microtubule alterations are associated with Vinca alkaloid resistance in human leukemia cells. Cancer Res. 2001, 61, 5803-5809.
11. Hagiwara, H., Sunada, Y., Mechanism of taxane neurotoxicity. Breast Cancer 2004, 11, 82-85.
12. Wood, K. W., Cornwell, W. D., Jackson, J. R., Past and future of the mitotic spindle as an oncology target. Curr. Opin. Pharmacol. 2001, 1, 370-377.
13. Jordan, M. A., Wilson, L., Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 2004, 4, 253-265.
14. Zhu, C., Zhao, J., Bibikova, M., Leverson, J. D. et al., Functional analysis of human microtubule-based motor proteins, the kinesins and dyneins, in mitosis/cytokinesis using RNA interference. Mol. Biol. Cell 2005, 16, 3187-3199.
15. Hirokawa, N., Takemura, R., Kinesin superfamily proteins and their various functions and dynamics. Exp. Cell Res. 2004, 301, 50-59.
16. Miki, H., Setou, M., Kaneshiro, K., Hirokawa, N., All kinesin superfamily protein, KIF, genes in mouse and human. Proc. Natl. Acad. Sci. USA 2001, 98, 7004-7011.
17. Miyamoto, D. T., Perlman, Z. E., Mitchison, T. J., Shirasu-Hiza, M., Dynamics of the mitotic spindle - potential therapeutic targets. Prog. Cell Cycle Res. 2003, 5, 349-360.
18. Bergnes, G., Brejc, K., Belmont, L., Mitotic kinesins: Prospects for antimitotic drug discovery. Curr. Top. Med. Chem. 2005, 5, 127-145.
19. Blangy, A., Lane, H. A., d'Herin, P., Harper, M. et al., Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 1995, 83, 1159-1169.
20. Whitehead, C. M., Rattner, J. B., Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle. J. Cell Sci. 1998, 111, 2551-2561.
21. Ferhat, L., Cook, C., Chauviere, M., Harper, M. et al., Expression of the mitotic motor protein Eg5 in postmitotic neurons: Implications for neuronal development. J. Neurosci. 1998, 18, 7822-7835.
22. Weil, D., Garcon, L., Harper, M., Dumenil, D. et al., Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 2002, 33, 1244-1248.
23. Sakowicz, R., Finer, J. T., Beraud, C., Crompton, A. et al., Antitumor activity of a kinesin inhibitor. Cancer Res. 2004, 64, 3276-3280.
24. Pauli, K. D., Lin, C. M., Malspeis, L., Hamel, E., Identification of novel antimitotic agents acting at the tubulin level by computer-assisted evaluation of differential cytotoxicity data. Cancer Res. 1992, 52, 3892-3900.
25. DeBonis, S., Skoufias, D. A., Robin, G., Lebeau, L. et al., In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities. Mol. Cancer Ther. 2004, 3, 1079-1090.
26. Yan, Y., Sardana, V., Xu, B., Homnick, C. et al., Inhibition of a mitotic motor protein: Where, how, and conformational consequences. J. Mol. Biol. 2003, 335, 547-554.
27. Brier, S., Lemaire, D., DeBonis, S., Forest, E., Kozielski, F., Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Biochemistry 2004, 43, 13072-13082.
28. Mayer, T. U., Kapoor, T. M., Haggarty, S. J., King, R. W. et al., Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999, 286, 971-974.
29. Skoufias, D. A., Debonis, S., Saoudi, Y., Lebeau, L. et al., S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression. J. Biol. Chem. 2006, 30, 17559-17569.
30. Thiede, B., Rudel, T., Proteome analysis of apoptotic cells. Mass Spectrom. Rev. 2004, 23, 333-349.
31. Machuy, N., Thiede, B., Rajalingam, K., Dimmler, C. et al., A global approach combining proteome analysis and phenotypic screening with RNA interference yields novel apoptosis regulators. Mol. Cell. Proteomics 2005, 4, 44-55.
32. Klose, J., Kobalz, U., Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 1995, 16, 1034-1059.
33. Thiede, B., Siejak, F., Dimmler, C., Jungblut, P. R., Rudel, T., A 2-DE database of a human Jurkat T-cell line. Electrophoresis 2000, 21, 2713-2720.
34. Candiano, G., Bruschi, M., Musante, L., Santucci, L. et al., Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 2004, 25, 1327-1333.
35. Jungblut, P. R., Seifert, R., Analysis by high-resolution 2-DE of differentiation-dependent alterations in cytosolic protein pattern of HL-60 leukemic cells. J. Biochem. Biophys. Methods 1990, 21, 47-58.
36. Thiede, B., Hohenwarter, W., Krah, A., Mattow, J. et al., Peptide mass fingerprinting. Methods 2005, 35, 237-247.
37. Perkins, D. N., Pappin, D. J., Creasy, D. M., Cottrell, J. S., Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20, 3551-3567.
38. Murray, A. W., Solomon, M. J., Kirschner, M. W., The role of cyclin synthesis and degradation in the control of maturation promoting factor activity. Nature 1989, 339, 280-286.
39. Hendzel, M. J., Wei, Y., Mancini, M. A., Van Hooser, A. et al., Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosome 1997, 106, 348-360.
40. Taylor, S. S., Hussein, D., Wang, Y., Elderkin, S., Morrow, C. J., Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J. Cell Sci. 2001, 114, 4385-4395.
41. Walter, A. O., Seghezzi, W., Korver, W., Sheung, J., Lees, E., The mitotic serine/threonine kinase Aurora2/AIK is regulated by phosphorylation and degradation. Oncogene 2000, 19, 4906-4916.
42. Leizerman, I., Avunie-Masala, R., Elkabets, M., Fich, A., Gheber, L., Differential effects of monastrol in two human cell lines. Cell. Mol. Life Sci. 2004, 61, 2060-2070.
43. Marcus, A. I., Peters, U., Thomas, S. L., Garrett, S. et al., Mitotic kinesin inhibitors induce mitotic arrest and cell death in Taxol-resistant and -sensitive cancer cells. J. Biol. Chem. 2005, 280, 11569-11577.
44. Tao, W., South, V. J., Zhang, Y., Davide, J. P. et al., Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Cancer Cell 2005, 8, 49-59.
45. Xiao, D., Pinto, J. T., Gundersen, G. G., Weinstein, I. B., Effects of a series of organosulfur compounds on mitotic arrest and induction of apoptosis in colon cancer cells. Mol. Cancer Ther. 2005, 4, 1388-1398.
46. Rich, T., Allen, R. L., Wyllie, A. H., Defying death after DNA damage. Nature 2000, 407, 777-783.
47. Kuwana, T., Newmeyer, D. D., Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol. 2003, 15, 691-699.
48. Debatin, K. M., Krammer, P. H., Death receptors in chemotherapy and cancer. Oncogene 2004, 23, 2950-2966.
49. Van Damme, P., Martens, L., Van Damme, J., Hugelier, K. et al., Caspase-specific and nonspecific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2005, 2, 771-777.
50. Frydman, J., Hohfeld, J., Chaperones get in touch: The Hip-Hop connection. Trends Biochem. Sci. 1997, 22, 87-92.
51. Hohfeld, J., Regulation of the heat shock conjugate Hsc70 in the mammalian cell: The characterization of the anti-apoptotic protein BAG-1 provides novel insights. Biol. Chem. 1998, 379, 269-274.
52. Bommer, U. A., Thiele, B. J., The translationally controlled tumour protein (TCTP). Int. J. Biochem. Cell Biol. 2004, 36, 379-385.
53. Liu, H., Peng, H. W., Cheng, Y. S., Yuan, H. S., Yang-Yen, H. F., Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol. Cell Biol. 2005, 25, 3117-3126.
54. Yang, Y., Yang, F., Xiong, Z., Yan, Y. et al., An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity. Oncogene 2005, 24, 4778-4788.
55. Paronetto, M. P., Achsel, T., Massiello, A., Chalfant, C. E., Sette, C., The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x. J. Cell Biol. 2007, 176, 929-939.
56. Gachet, Y., Tournier, S., Lee, M., Lazaris-Karatzas, A. et al., The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J. Cell. Sci. 1999, 112, 1257-1271.
57. Yarm, F. R., Plk phosphorylation regulates the microtubule-stabilizing protein TCTP. Mol. Cell Biol. 2002, 22, 6209-6221.
58. Fumagalli, S., Totty, N. F., Hsuan, J. J., Courtneidge, S. A., A target for Src in mitosis. Nature 1994, 368, 871-874.
59. Taylor, S. J., Shalloway, D., An RNA-binding protein associated with Src through its SH2 and SH3 domains in mitosis. Nature 1994, 368, 867-871.
60. Obuse, C., Iwasaki, O., Kiyomitsu, T., Goshima, G. et al., A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1. Nat. Cell Biol. 2004, 6, 1135-1141.
61. Gerner, C., Gotzmann, J., Fröhwein, U., Schamberger, C. et al., Proteome analysis of nuclear matrix proteins during apoptotic chromatin condensation. Cell Death Differ. 2002, 9, 671-681.
62. Andersen, S. S., Ashford, A. J., Tournebize, R., Gavet, O. et al., Mitotic chromatin regulates phosphorylation of Stathmin/Op18. Nature 1997, 389, 640-643.
63. Gu, S., Du, Y., Chen, J., Liu, Z. et al., Large-scale quantitative proteomic study of PUMA-induced apoptosis using two-dimensional liquid chromatography-mass spectrometry coupled with amino acid-coded mass tagging. J. Proteome Res. 2004, 3, 1191-1200.
64. Thiede, B., Kretschmer, A., Rudel, T., Quantitative proteome analysis of CD95 (Fas/Apo-1)-induced apoptosis by stable isotope labeling with amino acids in cell culture, 2-DE and MALDI-MS. Proteomics 2006, 6, 614-622.
65. Verrills, N. M., Liem, N. L., Liaw, T. Y., Hood, B. D. et al., Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia-an in vivo study. Proteomics 2006, 6, 1681-1694.